Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7732635

CC(C)(CN)c1cccc([N+](=O)[O-])c1Br.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.39
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
PDK4 Q16654 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
TSHR P16473 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HTT P42858 1/20 0.36
CES2 O00748 2/20 0.35
ACHE P22303 2/20 0.35
CES1 P23141 2/20 0.35
AR P10275 2/20 0.34
GPR35 Q9HC97 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CTSD P07339 1/20 0.34
ELANE P08246 1/20 0.34
CHIT1 Q13231 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5217375 0.75 NPSR1 (0.51) NPSR1PDK1PDK2PDK3PDK4
SCHEMBL7731390 0.74 NPSR1 (0.44) NPSR1TDP1TSHRL3MBTL1ALDH1A1
SCHEMBL7735993 0.74 NPSR1 (0.46) NPSR1PDK1PDK2PDK3PDK4
SCHEMBL7732543 0.73 TDP1 (0.46) NPSR1TDP1TSHRL3MBTL1ALDH1A1
SCHEMBL7775267 0.73 ALDH1A1 (0.46) NPSR1TDP1TSHRALDH1A1GPR35
SCHEMBL3126302 0.69 GPR35 (0.65) TDP1TSHRL3MBTL1ALDH1A1GPR35
Selenium SCHEMBL11463644 0.67 GPR35 (0.62) TDP1TSHRL3MBTL1ALDH1A1GPR35
SCHEMBL7731241 0.67 TDP1 (0.42) NPSR1TDP1TSHRL3MBTL1ALDH1A1
SCHEMBL22090177 0.66 NPSR1 (0.60) NPSR1PDK1PDK2PDK3PDK4
SCHEMBL12003841 0.66 NPSR1 (0.51) NPSR1PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407083-B1 ADMINISTERING AS 7-NITROBENZISOSELENAZOLINE DERIVATIVES AS ANTITUMOR AND ANTICARCINOGENIC AGENTS OXIS INTERNATIONAL, INC. 2002-06-18 US disclosed
US-6130212-A ANTITUMOR OXIS INTERNATIONAL S.A. (US) 2000-10-10 US disclosed
US-6057310-A TREATING LEUKEMIA, BREAST CANCER OXIS ISLE OF MAN, LIMITED (US) 2000-05-02 US disclosed
US-6001825-A Use of novel organoselenium compounds as pro-oxidizing agents their methods of preparation and pharmaceutical compositions and application thereof OXIS ISLE OF MAN, LIMITED (US) 1999-12-14 US disclosed
EP-0819682-A1 Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application containing them Oxis International S.A. (FR) 1998-01-21 EP disclosed